English
Home > Products > 1013916-37-4

China 1013916-37-4 Factory

We normally believe that one's character decides products' quality, the details decides products' high-quality ,while using the REALISTIC,EFFICIENT AND INNOVATIVE staff spirit for 1013916-37-4,CAS NO 1013916-37-4,Palbocilib intermediate,Palbocilib advance intermediate,2-chloro-8-cyclopentyl, We have now confident that we can easily offer the premium quality products and solutions at resonable price, good after-sales services into the buyers. And we're going to produce a dazzling future.
1013916-37-4, High output volume, top quality, timely delivery and your satisfaction are guaranteed. We welcome all inquiries and comments. If you are interested in any of our items or have an OEM order to fulfill, remember to feel free to contact us now. Working with us will save you money and time.

Related Products

Hot Products

  • Sarafloxacin hydrochloride

    Sarafloxacin hydrochloride

    Product Name:Sarafloxacin hydrochloride
    Molecular Formula:C20H18ClF2N3O3
    Molecular Weight;421.83
    CAS Registry Number;91296-87-6
  • Trichloroethanol

    Trichloroethanol

    Product Name:Trichloroethanol
    Molecular Formula:C2H3Cl3O
    Molecular Weight:149.4
    CAS Registry Number:115-20-8
  • Tetraethylammonium hydroxide

    Tetraethylammonium hydroxide

    Product Name:Tetraethylammonium hydroxide
    Molecular Formula:C8H21NO
    Molecular Weight:147.26
    CAS Registry Number:77-98-5
  • Levofloxacin Hydrochloride

    Levofloxacin Hydrochloride

    Product Name:Levofloxacin Hydrochloride
    Molecular Formula:C18H20FN3O4
    Molecular Weight:361.37
    CAS Registry Number:100986-85-4
  • S)-3-Cyano-5-methyl hexanoic acid ethyl ester

    S)-3-Cyano-5-methyl hexanoic acid ethyl ester

    Product Name:S)-3-Cyano-5-methyl hexanoic acid ethyl ester
    Molecular Formula:C10H17NO2
    Molecular Weight:183.25
    CAS Registry Number:181289-39-4
  • 3,4,5-Trifluorophenol

    3,4,5-Trifluorophenol

    Product Name:3,4,5-Trifluorophenol
    Molecular Formula:C6H3F3O
    Molecular Weight:148.08
    CAS Registry Number:99627-05-1
  • Related Blog
  • Reviews

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

Related Search

CAS NO 1013916-37-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept